All
FDA Approves Imfinzi Therapy in Muscle Invasive Bladder Cancer
The FDA approved neoadjuvant Imfinzi, gemcitabine and cisplatin, followed by adjuvant Imfinzi after radical cystectomy in muscle invasive bladder cancer.
Life Goes On, Even With Breast Cancer
I reflect on how cancer has brought out resilience and support in others, even as I struggled with my own battle, and wish others strength in their journeys.
Why Physical Therapy Should Begin at the Time of a Cancer Diagnosis
CURE spoke with Leslie Waltke about the importance of physical therapy during a cancer journey.
FDA Expands Pluvicto Indication in Prostate Cancer Subset
FDA expands Pluvicto indication to adults with PSMA+ metastatic castration-resistant prostate cancer previously treated with androgen receptor inhibitors.
SON-1010 Generates Safe Results in Advanced Sarcoma
A phase 1 trial has reported positive safety findings of SON-1010 among patients with advanced leiomyosarcoma (LMS) or liposarcoma (LPS).
Solnerstotug Demonstrates Early Efficacy in PD-L1 Resistant Tumors
Favorable initial results from a phase 1/2 trial of solnerstotug in PD-L1–resistant tumors showed a 14% response rate and 62% disease control rate.
Childhood Cancer Survivors May Experience Sooner Aging-Related Disease
Researchers have found childhood cancer survivors are at risk of experiencing onset of aging-related disease 17.7 years sooner than the general population.
Kidney Cancer Awareness Month Highlights Advocacy and Early Detection
March is Kidney Cancer Awareness Month, highlighting the disease, early detection and and patient advocacy, with voices like Sid Sadler raising awareness.
Clinical Trial to Evaluate Opdivo, Opdualag in Glioblastoma
The phase 2 GIANT trial will evaluate Opdivo with or without relatlimab in IDH-wildtype newly diagnosed glioblastoma.
Quadruplet Regimen Preferable to Triplets in Multiple Myeloma
Dr. Cesar Rodriguez discussed treatment advancements for multiple myeloma during a CURE Educated Patient® Summit.
Snow, A Wig, and Memories After My Breast Cancer Diagnosis
Cancer memories often sneak up on me when I least expect them to.
CAN-2409 Elicits Survival Responses In NSCLC
Treatment with CAN-2409, an off-the-shelf immunotherapy, elicited responses among patients with pretreated stage 3/4 non–small cell lung cancer.
Itolizumab Shows Long-Term Treatment Benefits in Acute GVHD
Although itolizumab did not improve response rates at Day 29 for patients with acute GVHD, the therapy showed significant benefits in long-term outcomes.
Rina-S Generates Antitumor Activity in Heavily Pretreated Ovarian Cancer
Treatment with Rina-S showed antitumor activity in heavily pretreated patients with advanced ovarian cancer, according to the phase 2 RAINFOL-01 study.
A VXM01 Vaccine Combination Generates Safe Responses in Glioblastoma
Treatment with VXM01, an investigational vaccine, plus Bavencio demonstrated both safety and tolerability in patients with recurrent glioblastoma.
A Patient Advocate Highlights Kidney Cancer Awareness and Specialized Care
Sid Sadler discusses kidney cancer awareness, patient advocacy and the need for specialized care to improve access to treatments and clinical trials.
Communication is Key When Transitioning Multiple Myeloma Care
A panel of experts discussed the transition of care between community and academic centers at the CURE Educated Patient Multiple Myeloma Summit.
Surviving Scans While Surviving Breast Cancer
Survivors facing new medical concerns may fear the unknown, but perseverance is possible as they navigate unexpected challenges in their new normal.
Progress Reported in Phase 1 Trial of CLD-101 for Recurrent Glioma
A progress report for a phase 1 trial of CLD-101 in recurrent glioma shows safety and feasibility at multiple intracerebral doses.
FDA Approves Cabometyx for Some Neuroendocrine Tumors
The FDA has approved Cabometyx for some patients 12 years old and older with pancreatic neuroendocrine tumors and extra-pancreatic neuroendocrine tumors.
Navigating a Colorectal Cancer Diagnosis at a Young Age
Melissa Ursini discussed her experience with a colorectal cancer diagnosis at age 37, highlighting her insights during Colorectal Cancer Awareness Month.
EU Approves Rytelo for Transfusion-Dependent Anemia in Low-Risk MDS
The European Commission has approved Rytelo treatment in transfusion-dependent anemia due to very low–, low– or intermediate-risk myelodysplastic syndrome.
Top 3 Takeaways From ASCO GU 2025
Dr. Emre Yekedüz discusses his top 3 key takeaways from attending the 2025 ASCO Genitourinary (GU) Cancers Symposium.
New Cancer Vaccine, EVM14, Cleared for Investigational Drug Application
EVM14 received FDA clearance for clinical trials, marking Everest Medicines’ first in-house developed therapeutic to reach this stage.
Navigating a Diagnosis of Diabetes and Chronic Lymphocytic Leukemia
Managing diabetes and chronic lymphocytic leukemia is challenging, but with proactive care, mindfulness and diet changes, I'm working to balance both.
Olvi-Vec Shows Responses and Tolerable Safety in Small Cell Lung Cancer
Positive preliminary data from the phase 1b/2 trial evaluating Olvi-Vec in small cell lung cancer have been announced.
First Patient Dosed with Efti in Phase 3 Trial for Non-Small Cell Lung Cancer
The first patient has been dosed in the phase 3 TACTI-004 trial evaluating efti with Keytruda and chemotherapy for advanced non-small cell lung cancer.
Raising Awareness for Colorectal Cancer, On the Rise in Younger Adults
During Colorectal Cancer Awareness Month, Dr. Shyam Thakkar discussed rates of this disease in young adults, the role of AI and disparities in care.
Global Submission Seeks Approval for Sugemalimab Treatment in NSCLC
An application was submitted to the European Medicines Agency seeking approval for treatment with sugemalimab in stage 3 NSCLC following chemoradiotherapy.
Dr. Sheri Prentiss on Steps for Lymphedema Screening in Breast Cancer
Dr. Sheri Prentiss discusses what steps patients can take to ensure they're being screened for lymphedema prior to starting their breast cancer treatment.
